跳至主要内容
临床试验/NCT00560651
NCT00560651进行中(未招募)不适用

German Corneal Cross Linking Register

Suphi Taneri4 个研究点 分布在 1 个国家目标入组 356 人开始时间: 2007年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
356
试验地点
4
主要终点
Keratometry

研究概览

简要总结

Corneal Cross Linking is new treatment modality for patients with keratoconus. A keratoconus is characterized by progressive bulging and thinning of the eye's cornea. Keratoconus is a potentially severely sight impairing condition that may necessitate corneal transplantation in the progressive state.

Corneal Cross Linking is designed to

  • increase the cornea's mechanical stability
  • to stop progression of bulging and thinning of the cornea
  • to prevent the need for corneal transplantation

Corneal Cross Linking is performed by

  1. Applying Riboflavin (Vitamin B2) eye drops every 2 minutes for 30 minutes to the cornea
  2. Illuminating the cornea with UV-light

This register of Corneal Cross Linking procedures performed in Germany serves to

  • gather long-term results
  • detect rare complications and side-effects
  • evaluate the efficacy in a large number of patients

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with keratokonus and treated with corneal cross Linking in Germany

排除标准

  • Non-ectatic conditions

结局指标

主要结局

Keratometry

时间窗: yearly

次要结局

  • Slit-lamp biomicroscopical findings(yearly)
  • Best corrected Visual Acuity(Yearly)

研究者

发起方
Suphi Taneri
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Suphi Taneri

Director

St. Franziskus Hospital

研究点 (4)

Loading locations...

相似试验